Exosome Diagnostics Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- Exosome Diagnostics's estimated annual revenue is currently $14.7M per year.
- Exosome Diagnostics received $30.0M in venture funding in July 2017.
- Exosome Diagnostics's estimated revenue per employee is $155,000
- Exosome Diagnostics's total funding is $106.9M.
- Exosome Diagnostics has 95 Employees.
- Exosome Diagnostics grew their employee count by 14% last year.
- Exosome Diagnostics currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Cell Signaling ...||$75.6M||488||N/A||N/A|
What Is Exosome Diagnostics?
Exosome Diagnostics, Inc. is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases. Exosomes are lipid bilayer covered microvesicles shed by solid tumors into body fluids, such as blood and urine. Exosomes contain nucleic acid profiles of cancers and other diseases. In published studies, Exosome Diagnostics has demonstrated the ability to extract exosomes from the blood and urine of patients, and to detect with high sensitivity and specificity key genes and gene mutations associated with a variety of cancers.keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals
Number of Employees
Employee Growth %
|Mikkel Noerholm||VP Product Development|
|Johan Skog||Chief Scientific Officer||Email Available|
|Steve Silverman||Vice President And General Manager||Email Available|
|Katherine Rich||Head Of Customer Service||Email Available|
|James Hurley||Director R&d (na Technology)||Email Available|
|Bill Tisel||Director, Project Management|
|Tom McLain||General Manager||Email Available|
|Anthony DiNardi||National Sales Director||Email Available|
|Stacey Shore-Reeves||Southeast Regional Sales Manager|
|Dalin Chan||Project Manager, Business Development||Email Available|
Exosome Diagnostics News
Exosome Diagnostics and Therapeutics market research report 2015-2024 helps businessman/investor avoiding unpleasant surprises. Intuition and experience ...
The global market for exosome diagnostics and therapeutics should grow from $34.7 million in 2018 to $186.2 million by 2023, with a ...
The Global Exosome Diagnostics and Therapeutics Market 2019 recently published report provides a unique overview market for the ...
Exosome Diagnostics Funding
|2010-05-13||$20.0M||Undisclosed||NGN Capital, Forbion Capital Partners||Article|
|2010-08-31||$20.0M||Undisclosed||NGN Capital, Forbion Capital Partners||Article|
Exosome Diagnostics Executive Hires
|2008-09-04||Wayne D. Comper||Chief Scientific Officer||Article|
|2008-09-15||Johan Skog||Dir Genetics Research||Article|
|2014-05-29||William J. Kelly||Chief Financial Officer||Article|
|2014-06-04||Vincent J. O'Neill||Cheif Medical Officer||Article|
|2015-12-23||Raajdeep Venkatesan||VP Regulatory Affairs Quality||Article|
|2016-05-24||John Healy||VP Informatics||Article|
|2016-06-07||Vasisht Tadigotla||Head of Informatics||Article|
|2016-06-28||Mario Morken||Director Business Development.||Article|
|2016-09-14||Elizabeth Cormier-May||Head of Commercial Diagnostics||Article|
|2018-03-22||Grannum Sant||Head of Medical Affairs||Article|
Exosome Diagnostics New Location/Offices